Shenzhen Citops Systems Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Citops Systems Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CITOPS. The owner is based in Shenzhen, Guangdong.

11/F, Block A, Delux Sci-Tech Park, No. 5 Guanle Road, LuHu Community

Guanhu Street, Longhua District

Shenzhen, Guangdong 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CITOPS
CITOPS
Registered 2025

Trademark Classifications

Shenzhen Citops Systems Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Citops Systems Co., Ltd. have?

Shenzhen Citops Systems Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Citops Systems Co., Ltd. file in?

Shenzhen Citops Systems Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Shenzhen Citops Systems Co., Ltd.'s most well-known trademarks?

Shenzhen Citops Systems Co., Ltd.'s registered trademark portfolio includes well-known marks such as CITOPS. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Citops Systems Co., Ltd.'s trademark registration success rate?

Shenzhen Citops Systems Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.